Biodesix Inc. (BDSX) reported Q2 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $8.83 million.
GUIDANCE:
Biodesix Inc. sees FY2022 revenue of $37.5-39.5 million, versus the consensus of $38.4 million.